Global Contraceptive Implants Market Overview
Western Market Research estimates that the Global Contraceptive Implants Market was valued at USD XXXX million in 2025 and is projected to reach USD XXXX million by 2036, registering a CAGR of XX% during the forecast period 2026–2036.
Contraceptive implants are long-acting reversible contraceptives (LARCs) that provide highly effective, hormone-based pregnancy prevention for several years with minimal user intervention. The market is driven by increasing awareness of family planning, rising preference for long-term and low-maintenance contraceptive methods, supportive government initiatives, and growing access to reproductive healthcare services in developing regions.
Technological progress in biocompatible polymers, hormone-release control, and minimally invasive insertion systems, combined with endorsements from public health agencies, continues to strengthen market adoption worldwide.
Impact of COVID-19 on the Contraceptive Implants Market
The COVID-19 pandemic temporarily disrupted family-planning services due to clinic closures and reduced elective healthcare visits. However, the market recovered as:
-
Governments prioritized essential reproductive health services
-
Demand increased for long-acting contraceptives requiring fewer follow-up visits
-
NGOs and public health programs resumed community-level distribution
Post-pandemic, contraceptive implants benefited from renewed focus on continuity of care and reproductive autonomy.
Global Contraceptive Implants Market Segmentation
By Product Type
-
Levonorgestrel Contraceptive Implants
-
Etonogestrel Contraceptive Implants
-
Next-Generation Hormonal Implants
By Duration of Effectiveness
-
Up to 3 Years
-
3–5 Years
-
More than 5 Years
By Application / End User
-
Hospitals
-
Clinics & Family Planning Centers
-
Community Health Programs
-
Others
By Distribution Channel
-
Public Healthcare Programs
-
Private Healthcare Providers
-
Non-Governmental Organizations (NGOs)
Regional Analysis
North America
-
High awareness and strong clinical adoption of LARCs
-
Favorable reimbursement and insurance coverage
-
Emphasis on patient education and choice
Europe
-
Widespread acceptance of hormonal implants
-
Strong government-supported family-planning initiatives
-
Stable demand across public and private healthcare systems
Asia-Pacific
-
Fastest-growing regional market
-
Large reproductive-age population
-
Expanding public health and NGO-led contraception programs
South America
-
Growing adoption supported by maternal health programs
-
Increasing access through public healthcare systems
Middle East & Africa
-
Gradual growth driven by international health organizations
-
Focus on reducing unintended pregnancies and improving maternal health
Competitive Landscape – Key Market Players
Competition is shaped by product efficacy, duration, safety profile, pricing, and access through public health programs. Key players include:
-
Bayer
-
Merck
-
Allergan
-
Shanghai Dahua Pharmaceuticals
-
Organon
-
Pfizer
-
Teva Pharmaceutical Industries
Porter’s Five Forces Analysis
-
Threat of New Entrants: Medium – regulatory and clinical validation requirements
-
Bargaining Power of Suppliers: Moderate – specialized hormone and polymer inputs
-
Bargaining Power of Buyers: High – government and NGO bulk procurement
-
Threat of Substitutes: Moderate – IUDs, injectables, oral contraceptives
-
Competitive Rivalry: Moderate – limited number of approved implant products
SWOT Analysis
Strengths
-
High efficacy and long duration
-
Minimal user compliance required
-
Strong public health endorsement
Weaknesses
-
Requires trained healthcare professionals for insertion/removal
-
Hormonal side-effect concerns in some users
Opportunities
-
Expansion in low- and middle-income countries
-
Development of next-generation, longer-lasting implants
-
Increased government funding for family planning
Threats
-
Cultural and social resistance in certain regions
-
Competition from non-hormonal contraceptive methods
Trend Analysis
-
Rising preference for long-acting reversible contraception (LARC)
-
Integration of implants into national family-planning programs
-
Innovation in biodegradable and extended-duration implants
-
Increased role of NGOs in awareness and distribution
-
Emphasis on women-centric reproductive healthcare
Market Drivers & Challenges
Key Drivers
-
Growing focus on reproductive health and family planning
-
High effectiveness and convenience of implants
-
Supportive government and NGO initiatives
Key Challenges
-
Limited awareness in rural areas
-
Cultural and religious barriers
-
Need for trained insertion providers
Value Chain Analysis
-
Hormonal API & Polymer Sourcing
-
Implant Manufacturing & Sterilization
-
Regulatory Approval & Quality Control
-
Distribution via Public & Private Channels
-
Implantation, Follow-Up & Removal Services
Strategic Recommendations for Stakeholders
-
Manufacturers: Invest in longer-acting and user-friendly implant designs
-
Governments & NGOs: Expand training programs for healthcare workers
-
Healthcare Providers: Improve counseling and patient education
-
Investors: Focus on Asia-Pacific and Africa growth opportunities
-
Policy Makers: Strengthen reimbursement and access to LARC methods
1. Market Overview of Contraceptive Implants
1.1 Contraceptive Implants Market Overview
1.1.1 Contraceptive Implants Product Scope
1.1.2 Market Status and Outlook
1.2 Contraceptive Implants Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Contraceptive Implants Historic Market Size by Regions
1.4 Contraceptive Implants Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Contraceptive Implants Sales Market by Type
2.1 Global Contraceptive Implants Historic Market Size by Type
2.2 Global Contraceptive Implants Forecasted Market Size by Type
2.3 Levonorgestrel Contraceptive Implants
2.4 Etonogestrel Contraceptive Implants
3. Covid-19 Impact Contraceptive Implants Sales Market by Application
3.1 Global Contraceptive Implants Historic Market Size by Application
3.2 Global Contraceptive Implants Forecasted Market Size by Application
3.3 Hospitals
3.4 Clinics
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Contraceptive Implants Production Capacity Market Share by Manufacturers
4.2 Global Contraceptive Implants Revenue Market Share by Manufacturers
4.3 Global Contraceptive Implants Average Price by Manufacturers
5. Company Profiles and Key Figures in Contraceptive Implants Business
5.1 Bayer HealthCare
5.1.1 Bayer HealthCare Company Profile
5.1.2 Bayer HealthCare Contraceptive Implants Product Specification
5.1.3 Bayer HealthCare Contraceptive Implants Production Capacity, Revenue, Price and Gross Margin
5.2 Merck
5.2.1 Merck Company Profile
5.2.2 Merck Contraceptive Implants Product Specification
5.2.3 Merck Contraceptive Implants Production Capacity, Revenue, Price and Gross Margin
5.3 Allergan
5.3.1 Allergan Company Profile
5.3.2 Allergan Contraceptive Implants Product Specification
5.3.3 Allergan Contraceptive Implants Production Capacity, Revenue, Price and Gross Margin
5.4 Shanghai Dahua Pharmaceuticals
5.4.1 Shanghai Dahua Pharmaceuticals Company Profile
5.4.2 Shanghai Dahua Pharmaceuticals Contraceptive Implants Product Specification
5.4.3 Shanghai Dahua Pharmaceuticals Contraceptive Implants Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Contraceptive Implants Market Size
6.2 North America Contraceptive Implants Key Players in North America
6.3 North America Contraceptive Implants Market Size by Type
6.4 North America Contraceptive Implants Market Size by Application
7. East Asia
7.1 East Asia Contraceptive Implants Market Size
7.2 East Asia Contraceptive Implants Key Players in North America
7.3 East Asia Contraceptive Implants Market Size by Type
7.4 East Asia Contraceptive Implants Market Size by Application
8. Europe
8.1 Europe Contraceptive Implants Market Size
8.2 Europe Contraceptive Implants Key Players in North America
8.3 Europe Contraceptive Implants Market Size by Type
8.4 Europe Contraceptive Implants Market Size by Application
9. South Asia
9.1 South Asia Contraceptive Implants Market Size
9.2 South Asia Contraceptive Implants Key Players in North America
9.3 South Asia Contraceptive Implants Market Size by Type
9.4 South Asia Contraceptive Implants Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Contraceptive Implants Market Size
10.2 Southeast Asia Contraceptive Implants Key Players in North America
10.3 Southeast Asia Contraceptive Implants Market Size by Type
10.4 Southeast Asia Contraceptive Implants Market Size by Application
11. Middle East
11.1 Middle East Contraceptive Implants Market Size
11.2 Middle East Contraceptive Implants Key Players in North America
11.3 Middle East Contraceptive Implants Market Size by Type
11.4 Middle East Contraceptive Implants Market Size by Application
12. Africa
12.1 Africa Contraceptive Implants Market Size
12.2 Africa Contraceptive Implants Key Players in North America
12.3 Africa Contraceptive Implants Market Size by Type
12.4 Africa Contraceptive Implants Market Size by Application
13. Oceania
13.1 Oceania Contraceptive Implants Market Size
13.2 Oceania Contraceptive Implants Key Players in North America
13.3 Oceania Contraceptive Implants Market Size by Type
13.4 Oceania Contraceptive Implants Market Size by Application
14. South America
14.1 South America Contraceptive Implants Market Size
14.2 South America Contraceptive Implants Key Players in North America
14.3 South America Contraceptive Implants Market Size by Type
14.4 South America Contraceptive Implants Market Size by Application
15. Rest of the World
15.1 Rest of the World Contraceptive Implants Market Size
15.2 Rest of the World Contraceptive Implants Key Players in North America
15.3 Rest of the World Contraceptive Implants Market Size by Type
15.4 Rest of the World Contraceptive Implants Market Size by Application
16 Contraceptive Implants Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Global Contraceptive Implants Market Segmentation
By Product Type
-
Levonorgestrel Contraceptive Implants
-
Etonogestrel Contraceptive Implants
-
Next-Generation Hormonal Implants
By Duration of Effectiveness
-
Up to 3 Years
-
3–5 Years
-
More than 5 Years
By Application / End User
-
Hospitals
-
Clinics & Family Planning Centers
-
Community Health Programs
-
Others
By Distribution Channel
-
Public Healthcare Programs
-
Private Healthcare Providers
-
Non-Governmental Organizations (NGOs)
Competitive Landscape – Key Market Players
Competition is shaped by product efficacy, duration, safety profile, pricing, and access through public health programs. Key players include:
-
Bayer
-
Merck
-
Allergan
-
Shanghai Dahua Pharmaceuticals
-
Organon
-
Pfizer
-
Teva Pharmaceutical Industries
